To confirm the in vivo relevance of pSer208, we also created a novel monoclonal antibody 3G12 specific for pSer208 and demonstrated its strong reactivity for tau inclusions in transgenic mouse models of tauopathies and in postmortem brain samples of patients with AD and other tauopathies. Here, MAPT is linked to tauopathy.